These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 23113992

  • 1. [Stereotactic radiotherapy and radiofrequency ablation for early-stage lung cancer].
    Piegay F, Girard N, Mornex JF.
    Bull Cancer; 2012 Nov; 99(11):1077-81. PubMed ID: 23113992
    [Abstract] [Full Text] [Related]

  • 2. [Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update].
    Girard N, Mornex F.
    Cancer Radiother; 2011 Oct; 15(6-7):522-6. PubMed ID: 21889901
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
    Abbas G, Danish A, Krasna MJ.
    Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ, Wee JO, Punglia RS.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e767-74. PubMed ID: 21300476
    [Abstract] [Full Text] [Related]

  • 5. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
    Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB.
    Cancer; 2015 Oct 01; 121(19):3491-8. PubMed ID: 26096694
    [Abstract] [Full Text] [Related]

  • 6. Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: advances and controversies in the management of early stage non-small cell lung cancer.
    Pennathur A, Abbas G, Christie N, Landreneau R, Luketich JD.
    Curr Opin Pulm Med; 2007 Jul 01; 13(4):267-70. PubMed ID: 17534171
    [Abstract] [Full Text] [Related]

  • 7. [Percutaneous lung thermo-ablation].
    Palussière J, Catena V, Gaubert JY, Buy X, de Baere T.
    Bull Cancer; 2017 May 01; 104(5):417-422. PubMed ID: 28477869
    [Abstract] [Full Text] [Related]

  • 8. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z, Taremi M, Bezjak A, Brade A, Hope AJ, Sun A, Cho BC.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1064-70. PubMed ID: 24210082
    [Abstract] [Full Text] [Related]

  • 9. Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials.
    Powell JW, Dexter E, Scalzetti EM, Bogart JA.
    Lancet Oncol; 2009 Sep 01; 10(9):885-94. PubMed ID: 19717090
    [Abstract] [Full Text] [Related]

  • 10. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033).
    Crabtree T, Puri V, Timmerman R, Fernando H, Bradley J, Decker PA, Paulus R, Putnum JB, Dupuy DE, Meyers B.
    J Thorac Cardiovasc Surg; 2013 Mar 01; 145(3):692-9. PubMed ID: 23174176
    [Abstract] [Full Text] [Related]

  • 11. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD, Fernando HC.
    Semin Thorac Cardiovasc Surg; 2013 Mar 01; 25(1):8-13. PubMed ID: 23800524
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
    Forquer JA, Fakiris AJ, McGarry RC, Cheung MK, Watson C, Harkenrider M, Henderson MA, Lo SS.
    Expert Rev Anticancer Ther; 2009 Oct 01; 9(10):1443-53. PubMed ID: 19828006
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, Huang Z, Grecula JC, Lo SS.
    Discov Med; 2010 May 01; 9(48):411-7. PubMed ID: 20515609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Aridgides P, Bogart J.
    Thorac Surg Clin; 2016 Aug 01; 26(3):261-9. PubMed ID: 27427521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.
    Cancer Radiother; 2013 Aug 01; 17(4):272-81. PubMed ID: 23712043
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.